ARMISTICE CAPITAL, LLC

Position in SRRK — Scholar Rock Holding Corp

CIK 1601086 NEW YORK, NY

Position in SRRK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$16,564,904

+$7,754,904 QoQ

Shares Held

336,959

+68.5% QoQ

Ownership

0.281%

of shares outstanding

% of Portfolio

0.54%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ARMISTICE CAPITAL, LLC holds $1,388,824,976 across 55 Biotechnology names. SRRK ranks #25 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	4,897,417	$145,502,259
2	PTCT	Ptc Therapeutics, Inc.	2,074,449	$141,332,210
3	MDGL	Madrigal Pharmaceuticals, Inc.	264,583	$138,501,263
4	AGIO	Agios Pharmaceuticals, Inc.	2,716,000	$91,882,280
5	IMVT	Immunovant, Inc.	3,564,916	$88,552,513
6	INCY	Incyte Corp	656,817	$61,819,616
7	DYN	Dyne Therapeutics, Inc.	3,175,110	$57,564,744
8	CYTK	Cytokinetics Inc	764,538	$50,390,699

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,564,904	336,959	+68.5%	Shares	Sole	2026-05-15
2025-12-31	$8,810,000	200,000	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.